Sulfonylurea compounds and their use in treating diabetes
US4505921A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Sep 6, 1983 |
| Grant date | Mar 19, 1985 |
| Priority date | — |
| Expiry date | Sep 6, 2003 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
New sulfonylurea compounds of the formula: ##STR1## in which n is 1 or 2, PA1 R is thienyl, furyl, pyridyl or phenyl optionally mono or disubstituted, PA1 R.sub.1 and R.sub.2, the same or different, each are hydrogen, halogen, (C.sub.1 to C.sub.5)-alkyl, (C.sub.1 to C.sub.5)-alkoxy, or trifluoromethyl, or together represent --CH.sub.2 --O--CH.sub.2 --, PA1 R.sub.3 is hydrogen, or hydroxy, and PA1 R.sub.4 is (C.sub.1 to C.sub.5)-alkyl, (C.sub.3 to C.sub.8)-cycloalkyl or azacycloalkyl of the formula: ##STR2## in which p is zero or an integer from 1 to 5, or azabicycloalkyl of the formula: ##STR3## in which m is 1, 2, or 3. These new compounds and physiologically tolerable salts thereof may be used as medicines especially in the treatment of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.